Clinical development of Modified Vaccinia virus Ankara vaccines.
The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivat...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2013
|